Lorraine A Cafuir

Outcomes of direct oral anticoagulant- and warfarin-associated hemorrhage: A single center retrospective cohort study.

C. Kempton, Lorraine A Cafuir, E. Cheng, 2019, Thrombosis research.

Current and emerging factor VIII replacement products for hemophilia A

C. Kempton, Lorraine A Cafuir, Lorraine A. Cafuir, 2017, Therapeutic advances in hematology.

Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study

E. Kraut, T. Buckner, Michael Wang, 2022, Journal of thrombosis and haemostasis : JTH.

Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult males with Hemophilia A without inhibitors

C. Kempton, H. Mead, D. Hinds, 2022, Journal of medical economics.

Emicizumab for hemophilia A without inhibitors

C. Kempton, M. Mancuso, R. Kruse-Jarres, 2019, Expert review of hematology.

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Sanjay R. Jain, Lorraine A Cafuir, Marjorie A. Curry, 2017 .

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

D. Lawson, A. Voloschin, Vita Kesner, 2018, Journal of Immunotherapy for Cancer.